Skip to content

Dutch nOcturnal and hoME dialysis Study To Improve Clinical Outcomes

Dutch nOcturnal and hoME dialysis Study To Improve Clinical Outcomes: quality-of-life, clinical outcomes and cost-effectiveness of home dialysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON23350
Enrollment
1600
Registered
2017-08-22
Start date
2017-12-20
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CKD, Home Dialysis, Peritoneal Dialysis, Home Haemodialysis, PROMs, Quality of Life, Cost-effectiveness, ESRD, Renal Replacement Therapy. nierfalen, chronische nierschade, thuisdialyse, peritoneale dialyse, thuishaemodialyse, kwaliteit van leven, kosteneffectiviteit, nierfunctievervangende therapie.

Interventions

Home dialysis, both peritoneal dialysis and home haemodialysis

Sponsors

VU University Medical Center Amsterdam (VUmc) University Medical Center Utrecht (UMCU)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Age > 18 years - indication to start with RRT - willingness to start with a form of RRT

Exclusion criteria

Exclusion criteria: - unwillingness to provide informed consent - life expectancy < 3 months - expected renal transplantation < 3 months

Design outcomes

Primary

MeasureTime frame
Quality of life, obtained from the following questionnaires: SF-12, Dialysis Symptom Index and EQ5D-5L

Secondary

MeasureTime frame
clinical outcomes (phosphate and anaemia control, nutritional status, infectious complications, hospitalisation, mortality) and cost-effectiveness.

Contacts

Public ContactB.C. Jaarsveld, van

Postbus 7057, 1007 MB

b.jaarsveld@vumc.nl020-4442673

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)